PolyPid to Host Virtual KOL Event on June 17, 2024, and Provide an Update on the Company’s Ongoing D-PLEX₁₀₀ Phase 3 Trial

June 10, 2024

https://www.globenewswire.com/news-release/2024/06/10/2895869/0/en/PolyPid-to-Host-Virtual-KOL-Event-on-June-17-2024-and-Provide-an-Update-on-the-Company-s-Ongoing-D-PLEX-Phase-3-Trial.html

PETACH TIKVA, Israel, June 10, 2024 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq:PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will host a virtual Key Opinion Leader (KOL) event on Monday, June 17, 2024, at 10:00 AM ET, to discuss the significant unmet medical need in surgical site infections and provide an update on the Company’s ongoing D-PLEX100 Phase 3 trial. To register, click here.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.